Bacteriology in acute exacerbation of chronic obstructive pulmonary disease in patients admitted to hospital

Scandinavian Journal of Infectious Diseases

Volumn 41, Issue 1, 2009, Pages 26-32

  Larsen, Mette V ^a   Janner, Julie H ^a   Nielsen, Susanne D ^a   Friis Møller, Alice ^a   Ringbaek, Thomas ^a   Lange, Peter ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; CORTICOSTEROID; ERYTHROMYCIN; GENTAMICIN; MEROPENEM; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; STEROID;

AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL FLORA; BACTERIUM CULTURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DENMARK; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HAEMOPHILUS INFLUENZAE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; NEUTROPHIL COUNT; NONHUMAN; OXYGEN THERAPY; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SPUTUM CULTURE; SPUTUM CYTODIAGNOSIS; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CULTURE MEDIA; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HAEMOPHILUS INFLUENZAE; HOSPITALIZATION; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MORAXELLA (BRANHAMELLA) CATARRHALIS; PSEUDOMONAS AERUGINOSA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM; YOUNG ADULT;

EID: 58049198428     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540802484828     Document Type: Article

References (28)

1. Lokke, A., Fabricius, PG, Vestbo, J., Marott, JL and Lange, P. (2007) Prevalence of chronic obstructive pulmonary disease in Copenhagen. Results from The Copenhagen City Heart Study. Ugeskr Laeger, 169, pp. 3956-3960.
2. Mannino, DM, Watt, G., Hole, D., Gillis, C., Hart, C. McConnachie, A. et al. (2006) The natural history of chronic obstructive pulmonary disease. Eur Respir J, 27, pp. 627-643.
3. Donaldson, GC, Seemungal, TA, Bhowmik, A. and Wedzicha, JA. (2002) Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax, 57, pp. 847-852.
4. Groenewegen, KH and Wouters, EF. (2003) Bacterial infections in patients requiring admission for an acute exacerbation of COPD: A 1-y prospective study. Respir Med, 97, pp. 770-777.
5. Seemungal, TA, Donaldson, GC, Paul, EA, Bestall, JC, Jeffries, DJ and Wedzicha, JA. (1998) Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 157, pp. 1418-1422.
6. Miravitlles, M. (2002) Exacerbations of chronic obstructive pulmonary disease: When are bacteria important?. Eur Respir J Suppl, 36, p. S9.
7. Burrows, B. and Earle, RH. (1969) Course and prognosis of chronic obstructive lung disease. A prospective study of 200 patients. N Engl J Med, 280, pp. 397-404.
8. Rivera-Fernandez, R., Navarrete-Navarro, P., Fernandez-Mondejar, E., Rodriguez-Elvira, M., Guerrero-Lopez, F. and Vazquez-Mata, G. (2006) Six-y mortality and quality of life in critically ill patients with chronic obstructive pulmonary disease. Crit Care Med, 34, pp. 2317-2324.
9. Sethi, S., Evans, N., Grant, BJ and Murphy, TF. (2002) New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med, 347, pp. 465-471.
10. Ko, FW, Ng, TK, Li, TS, Fok, JP, Chan, MC Wu, AK et al. (2005) Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong. Respir Med, 99, pp. 454-460.
11. Soler, N., Torres, A., Ewig, S., Gonzalez, J., Celis, R. El-Ebiary, M. et al. (1998) Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med, 157, pp. 1498-1505.
12. Miravitlles, M., Espinosa, C., Fernandez-Laso, E., Martos, JA, Maldonado, JA and Gallego, M. (1999) Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest, 116, pp. 40-46.
13. Wilkinson, TM, Patel, IS, Wilks, M., Donaldson, GC and Wedzicha, JA. (2003) Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 167, pp. 1090-1095.
14. Rosell, A., Monso, E., Soler, N., Torres, F., Angrill, J. Riise, G. et al. (2005) Microbiological determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med, 165, pp. 891-897.
15. Patel, IS, Seemungal, TA, Wilks, M., Lloyd-Owen, SJ, Donaldson, GC and Wedzicha, JA. (2002) Relationship between bacterial colonization and the frequency, character, and severity of COPD exacerbations. Thorax, 57, pp. 759-764.
16. White, AJ, Gompertz, S. and Stockley, RA. (2003) Chronic obstructive pulmonary disease: The aetiology of exacerbations of chronic obstructive pulmonary disease. Thorax, 58, pp. 73-80.
17. Rohde, G., Wiethege, A., Borg, I., Kauth, M., Bauer, TT Gillissen, A. et al. (2003) Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalization: A case-control study. Thorax, 58, pp. 37-42.
18. Seemungal, T., Harper-Owen, R., Bhowmik, A., Moric, I., Sanderson, G. Message, S. et al. (2001) Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 164, pp. 1618-1623.
19. Nair, B., Stapp, J., Stapp, L., Bugni, L., Van, DJ and Burns, JL. (2002) Utility of Gram staining for evaluation of the quality of cystic fibrosis sputum samples. J Clin Microbiol, 40, pp. 2791-2794.
20. Stockley, RA, O'Brien, C., Pye, A. and Hill, SL. (2000) Relationship of sputum colour to nature and outpatient management of acute exacerbations of COPD. Chest, 117, pp. 1638-1645.
21. Monso, E., Garcia-Aymerich, J., Soler, N., Farrero, E., Felez, MA Anto, JM et al. (2003) Bacterial infection in exacerbated COPD with changes in sputum characteristics. Epidemiol Infect, 131, pp. 799-804.
22. Calverley, PM, Anderson, JA, Celli, B., Ferguson, GT, Jenkins, C. Jones, PW et al. (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med, 356, pp. 775-789.
23. Wedzicha, JA, Calverley, PM, Seemungal, TA, Hagan, G., Ansari, Z. and Stockley, RA. (2008) The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med, 177, pp. 19-26.
24. Eller, J., Ede, A., Schaberg, T., Niederman, MS, Mauch, H. and Lode, H. (1998) Infective exacerbations of chronic bronchitis: Relation between bacteriological aetiology and lung function. Chest, 113, pp. 1542-1548.
25. Lieberman, D. (2003) Pseudomonal infections in patients with COPD: epidemiology and management. Am J Respir Med, 2, pp. 459-468.
26. Hoiby, N. (2002) New antimicrobials in the management of cystic fibrosis. J Antimicrob Chemother, 49, pp. 235-238.
27. Ram, FS, Rodriguez-Roisin, R., Granados-Navarrete, A., Garcia-Aymerich, J. and Barnes, NC (2006) Antibiotics for exacerbations of chronic obstructive pulmonary disease. p. CD004403.
28. Brand, RA. (2008) Local chemotherapy with primary closure of septic wounds by means of drainage and irrigation cannulae: M. N. Smith-Petersen (1886-1953), Carroll B. Larson, Williams Cochran, The 12th President of the AAOS 1943 (MNS-P). Clin Orthop Relat Res, 466, pp. 104-112.